Skip to content

Relationship Between Genitourinary and Respiratory Symptoms in Postmanopause

Investigation of the Relationship Between Genitourinary System Symptoms, Respiratory Functions, and Respiratory Muscle Strength in the Postmenopausal Period

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07651566
Enrollment
28
Registered
2026-06-16
Start date
2025-05-01
Completion date
2026-03-01
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

menopause, women, respiratory function, genitourinary function

Brief summary

The aim of this study is to evaluate the relationship between genitourinary system symptoms and respiratory function and respiratory muscle strength in postmenopausal women.

Detailed description

The study included 28 volunteer women who had entered menopause naturally and whose menopausal period had not exceeded eight years. The Bristol Female Lower Urinary Tract Symptoms Index (BFLUTS), the Postmenopausal Sexuality Questionnaire (PSQ), and a spirometer to measure respiratory function were used to evaluate the participants.

Interventions

None listed

Sponsors

Halic University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* being between 50-64 years of age, * having passed menopause no more than eight years ago, * having experienced at least one pregnancy, * being literate;

Exclusion criteria

* having received/currently receiving hormone replacement therapy, * having any respiratory system disorder; * having a serious chronic and/or metabolic disorder that may affect the outcome of the study; * having cooperation problems.

Design outcomes

Primary

MeasureTime frameDescription
Bristol Female Lower Urinary Tract Symptoms Index (BUTSI)at baselineThe BUTSI, for which a Turkish validity and reliability study has been conducted, consists of five sections evaluating storage symptoms; voiding symptoms ; urinary incontinence ; sexual function ; and quality of life The maximum total score is 60.A higher total score on the scale indicates a more negative impact on sexual life and quality of life, and more severe lower urinary tract symptoms.
Postmenopausal Sexuality Questionnaire (PSQ)at baselineThe MSCA, for which Turkish validity and reliability studies have been conducted, consists of a total of 36 items and nine sub-dimensions.The maximum total score is 100. A score of zero indicates the worst sexual function, while a score of 100 indicates the best sexual function (0-100).
Respiratory functionat baseline.The evaluation was performed using a Cosmed Pony FX brand spirometer, in accordance with the criteria.A forced vital capacity maneuver test was administered to assess the respiratory function of the participants. During the forced vital capacity maneuver, the participant was asked to take a deep breath and, when they could no longer breathe, to forcefully, quickly, and for an extended period exhale all the air from their lungs, then take another deep breath. As a result of this test, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and peak airflow rate (PEF) values were obtained and recorded.
respiratory muscle strengthat baseline.The evaluation was performed using a Cosmed Pony FX brand spirometer. Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) tests were performed to assess the strength of the respiratory muscles. For the MIP test, the participant was asked to first completely exhale the air from their lungs, followed by a deep, rapid, and forceful full breath; for the MEP test, the participant was asked to first completely fill their lungs with air, followed by a rapid and forceful full exhale. MIP and MEP values were used as percentages of the expected values for gender and age, and Black and Hyatt equations were used when interpreting the values.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORDuygu ŞAHİN, PT, PhD.

Halic University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026